Among them, the PD‐L1 expression is used in clinic for several cancer types, and some immunohistochemistry (IHC) assays to quantify PD‐L1 expression in tumour tissues have been approved by the U.S. Food and Drug Administration (FDA).5 Here, CD274 is linked to cancer.